(19)

(11)

EP 4 824 107 A1

(12)

(43) Date of publication: 21.10.2026 Bulletin 2026/43 (21) Application number: 24940924.4 (22) Date of filing: 13.11.2024

(51) International Patent Classification (IPC):  C07K 16/28(2006.01) A61K 39/395(2006.01) A61P 35/00(2006.01) C07K 14/705(2006.01) C12N 15/64(2006.01) C12N 5/0783(2010.01) (52) Cooperative Patent Classification (CPC): A61P 35/00; C07K 16/2818; C07K 2317/76; C07K 2317/33; C07K 2317/92; C07K 2317/565; A61K 2039/505; A61K 2039/507; A61K 2039/545; B60T 7/042; B60T 13/662; B60T 13/686; B60T 13/745 (86) International application number: PCT/IB2024/000811 (87) International publication number: WO 2025/128263 (19.06.2025 Gazette 2025/25)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 15.12.2023 US 202363610577 P (71) Applicant: PharmaEssentia Corporation Taipei 115 (TW)	(72) Inventors: YO, Yi-Te Taipei 115603 (TW) YAN, Shih-Long Taipei 115603 (TW) XU, Xu Hang Zhou City, Zheijiang Province 310000 (CN) CHEN, Ming-Tang Bedford, MA 01730 (US) LIN, Ko-Chung Lexington, MA 02421 (US) (74) Representative: Hertin und Partner Rechts- und Patentanwälte PartG mbB  Kurfürstendamm 63 10707 Berlin 10707 Berlin (DE)